CA71535/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
1997	1
2003	1
2008	1
2025	0

Page 1

Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.

Licitra EJ, Vyas V, Nelson K, Musanti R, Beers S, Thomas C, Poplin E, Smith S, Lin Y, Schaaf LJ, Aisner J, Gounder M, Rajendra R, Saleem A, Toppmeyer D, Rubin EH. Licitra EJ, et al. Clin Cancer Res. 2003 May;9(5):1673-9. Clin Cancer Res. 2003. PMID: 12738720 Clinical Trial.

Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.

Saraiya B, Gounder M, Dutta J, Saleem A, Collazo C, Zimmerman L, Nazar A, Gharibo M, Schaar D, Lin Y, Shih W, Aisner J, Strair RK, Rubin EH. Saraiya B, et al. Anticancer Drugs. 2008 Apr;19(4):411-20. doi: 10.1097/CAD.0b013e3282f5218b. Anticancer Drugs. 2008. PMID: 18454051 Clinical Trial.

Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.

Saleem A, Ibrahim N, Patel M, Li XG, Gupta E, Mendoza J, Pantazis P, Rubin EH. Saleem A, et al. Cancer Res. 1997 Nov 15;57(22):5100-6. Cancer Res. 1997. PMID: 9371509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year